ducovest

XHE:NYE-SPDR® S&P Health Care Equipment ETF (USD)

ETF | Health |

Last Closing

USD 88.94

Change

0.00 (0.00)%

Market Cap

USD 0.22B

Volume

2.60K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index (S&P TMI).

Company Website : http://www.spdrs.com

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-16 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

N/A

 USD 40.46B
FHLC Fidelity® MSCI Health Care In..

N/A

 USD 2.91B
FXH First Trust Health Care AlphaD..

N/A

 USD 1.19B
IDNA iShares Genomics Immunology an..

N/A

 USD 0.15B
SBIO ALPS Medical Breakthroughs ETF

N/A

 USD 0.13B
XHS SPDR® S&P Health Care Service..

N/A

 USD 0.08B
HTEC Robo Global® Healthcare Techn..

N/A

 USD 0.06B
BBP Virtus LifeSci Biotech Product..

N/A

 USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

N/A

 USD 0.01B
IHE iShares U.S. Pharmaceuticals E..

N/A

 N/A

ETFs Containing XHE

INAV 0.00 % 0.00 %

N/A

 N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.55% 71% C- 48% F
Dividend Return 0.01% 6% D- 1% F
Total Return 5.56% 71% C- 37% F
Trailing 12 Months  
Capital Gain 21.49% 71% C- 65% D
Dividend Return 0.05% 6% D- 1% F
Total Return 21.53% 71% C- 59% D-
Trailing 5 Years  
Capital Gain 7.92% 19% F 50% F
Dividend Return 0.09% 6% D- 1% F
Total Return 8.01% 19% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain 0.17% 29% F 33% F
Dividend Return 0.18% 29% F 23% F
Total Return 0.01% 5% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 26.68% 33% F 41% F
Risk Adjusted Return 0.67% 29% F 22% F
Market Capitalization 0.22B 70% C- 37% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.